ArticleEcancermedicalscience2019

Assessing the tolerability and efficacy of first-line chemotherapy in elderly patients with metastatic HER2-ve breast cancer.

Thomas Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.